JNK3 inhibitors as promising pharmaceuticals with neuroprotective properties
ABSTRACTThe intensive study and investigation of neuroprotective therapy for central nervous system (CNS) diseases is ongoing. Due to shared mechanisms of neurodegeneration, a neuroprotective approach might offer benefits across multiple neurological disorders, despite variations in symptoms or inju...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Cell Adhesion & Migration |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19336918.2024.2316576 |